Biohaven Pharma CEO: We're looking to end 30-year drought in new migraine prevention drugs

Jim Cramer speaks with Biohaven Pharmaceutical CEO Vlad Coric on company's late-stage drug to treat migraines.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:

#CNBC
#CNBC TV

CNBC,Mad Money,invest,investing,stock market,jim cramer,cramer,kramer,wall street,lightning round,investment strategy,retirement,